Cytokinetics's total assets for Q1 2026 were $1.27B, a decrease of -10.60% from the previous quarter. CYTK total liabilities were $2.10B for the fiscal quarter, a 0.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.